Pharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, metabolic diseases, cardiovascular diseases, neurological diseases, age-related diseases, immunological diseases, and genetic diseases, pharmaceuticals for the treatment of diseases and disorders with genetic etiology, gene therapies, and nucleic acid therapies; house mark for pharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, metabolic diseases, cardiov...